Alisa G. Woods, PhD

Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.

Did an active schedule help or hinder cognitive skills such as memory, reasoning, and crystallized knowledge in a group of adults aged 50-89 years?

New research in a mouse model could have implications for recovery of function in individuals who have suffered more than one stroke.

By studying first-degree relatives of patients with MS, can researchers perfect a risk algorithm for the disease?

Although not scientifically proven, there is a strong causal relationship between Zika infection and two severe neurological disorders.

Is there an association between high potency cannabis as well as frequency of use and damage to the corpus callosum?

Other studies have shown some induction of serotonin neurons from stem cells, but a recent study presents by far the most promising results.

A groundbreaking discovery may lead to repair of neurodegenerative diseases such as Alzheimer and Parkinson.

The discovery of a possible trigger for PD and Lewy body dementia could provide a new avenue for gene therapy in these neurological conditions.

Explore a case study and discussion with an expert on hallucinogen persisting perception disorder, a rare persisting visual condition.

A recent webinar summarized on-going efforts to halt Parkinson disease, including several phase III trials.

Research findings indicate that signs of Alzheimer may begin earlier than previously thought and genotyping could identify those at risk.

Dysregulated dopamine may not be the sole cause of impulse control problems in patients with Parkinson disease.

Researchers studied type 2 diabetes-induced neurodegeneration and the possible link to Alzheimer disease.

Dopamine may not be the only neurotransmitter affected in Parkinson disease.

Researchers test a compound that shows promise as a Parkinson treatment.

Researchers found associations between cognitive test scores and eventual Alzheimer disease.

Studies of a kuru epidemic in a formerly cannibalistic tribe could lead to further understanding of other neurodegenerative diseases, such as Alzheimer and Parkinson.

An international research group sought to uncover the link between Alzheimer disease and its numerous risk factors.

Discover 3 exciting developments in Alzheimer disease research.

New PD medications and treatments are being developed and novel uses for existing drugs are being discovered.

Graph theory applied to epilepsy, an abbreviated QOLCE, promising new interventions for neonatal seizures, a minipump to deliver drugs-the latest developments in epilepsy diagnosis and patient care.

Proteins linked in a pathway, drugs that may prevent memory loss, the positive role of sleep, a new memory app-check out these latest new concepts in AD diagnosis and treatment.

Deep brain stimulation, stem cell treatment, studying mitochondria-to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.

A new way to treat dementia and other diagnosis and treatment developments are in the news.

There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.

Focused ultrasound works like a noninvasive knife, cutting away amyloid plaques in mice. But is this new method safe and effective in humans?

These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.